Leuprorelin Injection Kit 22.5 mg
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Leuprorelin Injection Kit 22.5 mg, covering 2019-11-01 to 2019-11-01. Get the full timeline:
Most recent: Clinical Trial Update: Special Drug Use Surveillance of Leuprorelin for Injection Kit 22.5 mg in "Premenopausal Breast Cancer"